Olema Pharmaceuticals, Inc. (OLMA) earnings
OLMA earnings moved a median of -3.92% by the close. Quarterly and annual OLMA reports and results, each read against the price at its own news timestamp. Back to the OLMA overview →
19 measured OLMA earnings events.
Where these OLMA earnings landedvs 17 measured OLMA earnings reactions
| Middle 50% of OLMA earnings reactions | -11.42% to +1.90% |
|---|---|
| Median reaction (to close) | -3.92% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 OLMA earnings events with a measured close landed between -11.42% and +1.90%; 29% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Olema Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.14% | -3.92% | |
| Olema Oncology Reports First Quarter 2026 Financial and Operating Results | Press release | -1.14% | -3.92% | |
| Form 10-K Olema Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.86% | +9.93% | |
| Form 10-Q Olema Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +2.63% | +4.19% | |
| Olema Oncology Reports Third Quarter 2025 Financial and Operating Results | Press release | +2.63% | +4.19% | |
| Form 10-Q Olema Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +8.00% | — | |
| Olema Oncology Reports Second Quarter 2025 Financial and Operating Results | Press release | +8.00% | — | |
| Form 10-Q Olema Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -3.15% | -11.42% | |
| Olema Oncology Reports First Quarter 2025 Financial and Operating Results | Press release | -3.15% | -11.42% | |
| Form 10-K Olema Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +2.36% | -10.07% | |
| Form 10-Q Olema Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +2.99% | -3.45% | |
| Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +2.99% | -3.45% | |
| Form 10-Q Olema Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -1.40% | -11.80% | |
| Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -1.40% | -11.80% | |
| Form 10-Q Olema Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -10.00% | -13.68% | |
| Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | -10.00% | -13.68% | |
| Form 10-K Olema Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +3.09% | -6.25% | |
| Form 10-Q Olema Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -6.12% | +1.90% | |
| Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | -6.12% | +1.90% |
Keep exploring
More OLMA: analyst actions → · SEC filings → · OLMA overview →